InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,386.50
(
0.22%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: BTH post# 2598

Monday, 10/18/2010 10:21:04 AM

Monday, October 18, 2010 10:21:04 AM

Post# of 80490

And despite disagreeing with Don about all this, I do hope he is right....

We should know soon enough :)

I do disagree with your characterization that any sarcoma sub-type had an equal chance of being enrolled in the phase 3. As I pointed out to you here, sarcomas that respond well to chemo had a much greater chance to be included in the phase 3 trial, consequently, the premise underlying your "pick one" "50/50" argument is fundamentally flawed.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up